ArticleClinical lymphoma, myeloma & leukemia2011

Outcome of treatment of chronic myeloid leukemia with second-generation tyrosine kinase inhibitors after imatinib failure.

A Megan Cornelison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.